由MNK驱动的eIF4E酸化调节介质细胞的纤维化转化和慢性肺异位移植功能障碍
Natalie M Walker1, Yuta Ibuki1, A Patrick McLinden2
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
The Journal of clinical investigation
|August 15, 2024
概括
用抑制剂向MNK/eIF4E通路可以治疗组织纤维化. 这项研究揭示了一种新的信号通路,该通路对介质细胞激活和纤维性疾病至关重要,包括慢性肺异位移植功能障碍.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 翻译医学是一种翻译医学.
背景情况:
- 组织纤维化是慢性移植失败的主要原因,缺乏有效的治疗方法.
- 介酶细胞激活是纤维化的核心,由信号通路与真核细胞翻译启动因子 (eIF4E) 交汇驱动.
研究的目的:
- 为了研究MAP激酶与氨酸/氨酸激酶 (MNK) 相互作用的eIF4E在氨酸209 (Ser209) 处诱导的酸化在介质细胞纤维化转化中的作用.
- 确定MNK/eIF4E途径对慢性肺异位移植功能障碍 (CLAD) 的贡献.
主要方法:
- 在CLAD患者中介细胞中对Ser209的eIF4E酸化的分析.
- 研究了自毒素和β-catenin信号的调节.
- 在体外利用了MNK1活性的遗传和药理抑制.
- 在小鼠肺移植模型中评估了一种MNK1/2抑制剂 (eFT-508).
主要成果:
- 来自CLAD患者的介质细胞显示eIF4E光-Ser209.9的升高.
- eIF4E素-Ser209具有关键调节的自毒素,导致β-catenin激活和益纤维功能.
- 在CLAD介质细胞中,MNK1信号被上调.
- 抑制MNK1降低了eIF4E-Ser209和益纤维功能.
- 在体内,eFT-508治疗预防了全移植纤维化.
结论:
- 确定了一种新的MNK/eIF4E/自毒素/β-catenin信号通路,该通路驱动介质细胞的纤维化转化.
- 证明了MNK抑制剂治疗纤维化症的治疗潜力,包括慢性肺异位移植功能障碍.
更多相关视频
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
5.1K
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11.3K
相关概念视频
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
